NewsBusiness Larimar’s Friedreich’s ataxia asset nomlabofusp chosen for FDA accelerated program May 31, 2024 0 Facebook Twitter Pinterest WhatsApp ReddIt Larimar's Friedreich's ataxia asset nomlabofusp chosen for FDA accelerated program